Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global Natural Killer Cells Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Research Centers & Institutes
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Natural Killer Cells Therapeutics Market Perspective (2018-2033)
2.2 Natural Killer Cells Therapeutics Growth Trends by Region
2.2.1 Global Natural Killer Cells Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Natural Killer Cells Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Natural Killer Cells Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Natural Killer Cells Therapeutics Market Dynamics
2.3.1 Natural Killer Cells Therapeutics Industry Trends
2.3.2 Natural Killer Cells Therapeutics Market Drivers
2.3.3 Natural Killer Cells Therapeutics Market Challenges
2.3.4 Natural Killer Cells Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Natural Killer Cells Therapeutics Players by Revenue
3.1.1 Global Top Natural Killer Cells Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Natural Killer Cells Therapeutics Revenue
3.4 Global Natural Killer Cells Therapeutics Market Concentration Ratio
3.4.1 Global Natural Killer Cells Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cells Therapeutics Revenue in 2022
3.5 Natural Killer Cells Therapeutics Key Players Head office and Area Served
3.6 Key Players Natural Killer Cells Therapeutics Product Solution and Service
3.7 Date of Enter into Natural Killer Cells Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Natural Killer Cells Therapeutics Breakdown Data by Type
4.1 Global Natural Killer Cells Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2024-2033)
5 Natural Killer Cells Therapeutics Breakdown Data by Application
5.1 Global Natural Killer Cells Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Natural Killer Cells Therapeutics Market Size (2018-2033)
6.2 North America Natural Killer Cells Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Natural Killer Cells Therapeutics Market Size by Country (2018-2023)
6.4 North America Natural Killer Cells Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Natural Killer Cells Therapeutics Market Size (2018-2033)
7.2 Europe Natural Killer Cells Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Natural Killer Cells Therapeutics Market Size by Country (2018-2023)
7.4 Europe Natural Killer Cells Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Natural Killer Cells Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Natural Killer Cells Therapeutics Market Size (2018-2033)
9.2 Latin America Natural Killer Cells Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Natural Killer Cells Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Natural Killer Cells Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Natural Killer Cells Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Affimed
11.1.1 Affimed Company Detail
11.1.2 Affimed Business Overview
11.1.3 Affimed Natural Killer Cells Therapeutics Introduction
11.1.4 Affimed Revenue in Natural Killer Cells Therapeutics Business (2018-2023)
11.1.5 Affimed Recent Development
11.2 Celgene Corporation
11.2.1 Celgene Corporation Company Detail
11.2.2 Celgene Corporation Business Overview
11.2.3 Celgene Corporation Natural Killer Cells Therapeutics Introduction
11.2.4 Celgene Corporation Revenue in Natural Killer Cells Therapeutics Business (2018-2023)
11.2.5 Celgene Corporation Recent Development
11.3 Fate Therapeutics
11.3.1 Fate Therapeutics Company Detail
11.3.2 Fate Therapeutics Business Overview
11.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Introduction
11.3.4 Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2018-2023)
11.3.5 Fate Therapeutics Recent Development
11.4 Fortress Biotech
11.4.1 Fortress Biotech Company Detail
11.4.2 Fortress Biotech Business Overview
11.4.3 Fortress Biotech Natural Killer Cells Therapeutics Introduction
11.4.4 Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2018-2023)
11.4.5 Fortress Biotech Recent Development
11.5 Glycostem Therapeutics
11.5.1 Glycostem Therapeutics Company Detail
11.5.2 Glycostem Therapeutics Business Overview
11.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Introduction
11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2018-2023)
11.5.5 Glycostem Therapeutics Recent Development
11.6 Innate Pharma
11.6.1 Innate Pharma Company Detail
11.6.2 Innate Pharma Business Overview
11.6.3 Innate Pharma Natural Killer Cells Therapeutics Introduction
11.6.4 Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2018-2023)
11.6.5 Innate Pharma Recent Development
11.7 Nantkwest
11.7.1 Nantkwest Company Detail
11.7.2 Nantkwest Business Overview
11.7.3 Nantkwest Natural Killer Cells Therapeutics Introduction
11.7.4 Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2018-2023)
11.7.5 Nantkwest Recent Development
11.8 Nkarta Therapeutics
11.8.1 Nkarta Therapeutics Company Detail
11.8.2 Nkarta Therapeutics Business Overview
11.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Introduction
11.8.4 Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2018-2023)
11.8.5 Nkarta Therapeutics Recent Development
11.9 NKT Therapeutics
11.9.1 NKT Therapeutics Company Detail
11.9.2 NKT Therapeutics Business Overview
11.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Introduction
11.9.4 NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2018-2023)
11.9.5 NKT Therapeutics Recent Development
11.10 Ziopharm Oncology
11.10.1 Ziopharm Oncology Company Detail
11.10.2 Ziopharm Oncology Business Overview
11.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Introduction
11.10.4 Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2018-2023)
11.10.5 Ziopharm Oncology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of NK Cell Therapies
Table 3. Key Players of NK Cell Directed Antibodies
Table 4. Global Natural Killer Cells Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Natural Killer Cells Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Natural Killer Cells Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Natural Killer Cells Therapeutics Market Share by Region (2018-2023)
Table 8. Global Natural Killer Cells Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Natural Killer Cells Therapeutics Market Share by Region (2024-2033)
Table 10. Natural Killer Cells Therapeutics Market Trends
Table 11. Natural Killer Cells Therapeutics Market Drivers
Table 12. Natural Killer Cells Therapeutics Market Challenges
Table 13. Natural Killer Cells Therapeutics Market Restraints
Table 14. Global Natural Killer Cells Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Natural Killer Cells Therapeutics Market Share by Players (2018-2023)
Table 16. Global Top Natural Killer Cells Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2022)
Table 17. Ranking of Global Top Natural Killer Cells Therapeutics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Natural Killer Cells Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Natural Killer Cells Therapeutics Product Solution and Service
Table 21. Date of Enter into Natural Killer Cells Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Natural Killer Cells Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2018-2023)
Table 25. Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2024-2033)
Table 27. Global Natural Killer Cells Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Natural Killer Cells Therapeutics Revenue Market Share by Application (2018-2023)
Table 29. Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Natural Killer Cells Therapeutics Revenue Market Share by Application (2024-2033)
Table 31. North America Natural Killer Cells Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Natural Killer Cells Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Natural Killer Cells Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Natural Killer Cells Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Natural Killer Cells Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Natural Killer Cells Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Natural Killer Cells Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Natural Killer Cells Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Natural Killer Cells Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Natural Killer Cells Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Natural Killer Cells Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Affimed Company Detail
Table 47. Affimed Business Overview
Table 48. Affimed Natural Killer Cells Therapeutics Product
Table 49. Affimed Revenue in Natural Killer Cells Therapeutics Business (2018-2023) & (US$ Million)
Table 50. Affimed Recent Development
Table 51. Celgene Corporation Company Detail
Table 52. Celgene Corporation Business Overview
Table 53. Celgene Corporation Natural Killer Cells Therapeutics Product
Table 54. Celgene Corporation Revenue in Natural Killer Cells Therapeutics Business (2018-2023) & (US$ Million)
Table 55. Celgene Corporation Recent Development
Table 56. Fate Therapeutics Company Detail
Table 57. Fate Therapeutics Business Overview
Table 58. Fate Therapeutics Natural Killer Cells Therapeutics Product
Table 59. Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2018-2023) & (US$ Million)
Table 60. Fate Therapeutics Recent Development
Table 61. Fortress Biotech Company Detail
Table 62. Fortress Biotech Business Overview
Table 63. Fortress Biotech Natural Killer Cells Therapeutics Product
Table 64. Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2018-2023) & (US$ Million)
Table 65. Fortress Biotech Recent Development
Table 66. Glycostem Therapeutics Company Detail
Table 67. Glycostem Therapeutics Business Overview
Table 68. Glycostem Therapeutics Natural Killer Cells Therapeutics Product
Table 69. Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2018-2023) & (US$ Million)
Table 70. Glycostem Therapeutics Recent Development
Table 71. Innate Pharma Company Detail
Table 72. Innate Pharma Business Overview
Table 73. Innate Pharma Natural Killer Cells Therapeutics Product
Table 74. Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2018-2023) & (US$ Million)
Table 75. Innate Pharma Recent Development
Table 76. Nantkwest Company Detail
Table 77. Nantkwest Business Overview
Table 78. Nantkwest Natural Killer Cells Therapeutics Product
Table 79. Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2018-2023) & (US$ Million)
Table 80. Nantkwest Recent Development
Table 81. Nkarta Therapeutics Company Detail
Table 82. Nkarta Therapeutics Business Overview
Table 83. Nkarta Therapeutics Natural Killer Cells Therapeutics Product
Table 84. Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2018-2023) & (US$ Million)
Table 85. Nkarta Therapeutics Recent Development
Table 86. NKT Therapeutics Company Detail
Table 87. NKT Therapeutics Business Overview
Table 88. NKT Therapeutics Natural Killer Cells Therapeutics Product
Table 89. NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2018-2023) & (US$ Million)
Table 90. NKT Therapeutics Recent Development
Table 91. Ziopharm Oncology Company Detail
Table 92. Ziopharm Oncology Business Overview
Table 93. Ziopharm Oncology Natural Killer Cells Therapeutics Product
Table 94. Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2018-2023) & (US$ Million)
Table 95. Ziopharm Oncology Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Natural Killer Cells Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Natural Killer Cells Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. NK Cell Therapies Features
Figure 4. NK Cell Directed Antibodies Features
Figure 5. Global Natural Killer Cells Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Natural Killer Cells Therapeutics Market Share by Application: 2022 VS 2033
Figure 7. Research Centers & Institutes Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Others Case Studies
Figure 10. Natural Killer Cells Therapeutics Report Years Considered
Figure 11. Global Natural Killer Cells Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Natural Killer Cells Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Natural Killer Cells Therapeutics Market Share by Region: 2022 VS 2033
Figure 14. Global Natural Killer Cells Therapeutics Market Share by Players in 2022
Figure 15. Global Top Natural Killer Cells Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Natural Killer Cells Therapeutics Revenue in 2022
Figure 17. North America Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Natural Killer Cells Therapeutics Market Share by Country (2018-2033)
Figure 19. United States Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Natural Killer Cells Therapeutics Market Share by Country (2018-2033)
Figure 23. Germany Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Natural Killer Cells Therapeutics Market Share by Region (2018-2033)
Figure 31. China Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Natural Killer Cells Therapeutics Market Share by Country (2018-2033)
Figure 39. Mexico Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Natural Killer Cells Therapeutics Market Share by Country (2018-2033)
Figure 43. Turkey Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Natural Killer Cells Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Affimed Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2018-2023)
Figure 46. Celgene Corporation Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2018-2023)
Figure 47. Fate Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2018-2023)
Figure 48. Fortress Biotech Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2018-2023)
Figure 49. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2018-2023)
Figure 50. Innate Pharma Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2018-2023)
Figure 51. Nantkwest Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2018-2023)
Figure 52. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2018-2023)
Figure 53. NKT Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2018-2023)
Figure 54. Ziopharm Oncology Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed